Inmed Pharmaceuticals Inc. · NASDAQ:INM
Sabby Management, LLC reported a 9.90% stake in Inmed Pharmaceuticals Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Jan 20, 2026
Sabby Management, LLC reported a 9.90% stake in Inmed Pharmaceuticals Inc., 280,138 shares, as a passive investor on Dec 31, 2025. Filed Jan 20, 2026 (Schedule 13G).
- Stake
- 9.90%
- Shares
- 280,138
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| SABBY MANAGEMENT, LLC | 9.90% | 280,138 |
| Hal Mintz | 9.90% | 280,138 |
| Sabby Volatility Warrant Master Fund, Ltd. | 9.90% | 280,138 |
Source
Related
- Inmed Pharmaceuticals Inc.
- Sabby Management, LLC
- Inmed Pharmaceuticals Inc. shareholders
- Form 4 · ADAR1 Capital Management, LLC · Oct 20, 2026
- Form 4 · ADAR1 Capital Management, LLC · Oct 15, 2026
- Form 4 · ADAR1 Capital Management, LLC · Oct 8, 2026
- Schedule 13G/A · ADAR1 Capital Management, LLC · Oct 7, 2026
- Form 4 · ADAR1 Capital Management, LLC · Oct 5, 2026